Shortage reports
Actual shortage:
58 (4%)
Anticipated shortage:
2 (0%)
Avoided shortage:
37 (3%)
Resolved:
1273 (93%)
1370
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
287 (99%)
Reversed:
2 (1%)
291
211 (13%)
11 (18%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-MOXIFLOXACIN | 0.5% | SOLUTION | Resolved | 2024-08-02 | 2024-09-30 | 234387 |
| PMS-MOXIFLOXACIN | 0.5% | SOLUTION | Resolved | 2022-03-04 | 2022-06-23 | 156105 |
| PMS-MOXIFLOXACIN | 0.5% | SOLUTION | Resolved | 2023-06-09 | 2023-08-07 | 194530 |
| PMS-MOXIFLOXACIN | 0.5% | SOLUTION | Resolved | 2017-09-19 | 2018-06-07 | 22792 |
| PMS-NABILONE | 0.5MG | CAPSULE | Resolved | 2019-03-01 | 2019-07-29 | 77195 |
| PMS-NABILONE | 1.0MG | CAPSULE | Resolved | 2019-03-01 | 2019-07-29 | 77191 |
| PMS-NABILONE | 1.0MG | CAPSULE | Resolved | 2017-04-04 | 2019-01-25 | 5508 |
| PMS-NABILONE | 1.0MG | CAPSULE | Resolved | 2017-09-08 | 2019-01-25 | 21679 |
| PMS-NABILONE | 0.5MG | CAPSULE | Resolved | 2017-09-08 | 2019-01-25 | 21676 |
| PMS-NABILONE | 0.5MG | CAPSULE | Resolved | 2017-04-04 | 2019-01-25 | 5505 |
| PMS-NABILONE | 0.5MG | CAPSULE | Resolved | 2019-06-28 | 2019-07-29 | 87983 |
| PMS-NAPROXEN | 500MG | SUPPOSITORY | Resolved | 2017-04-07 | 2020-06-10 | 6142 |
| PMS-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2017-04-07 | 2020-06-10 | 6145 |
| PMS-NIFEDIPINE ER | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-04-20 | 2017-07-19 | 7447 |
| PMS-NIFEDIPINE ER | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-04-20 | 2017-12-18 | 7450 |
| PMS-NIFEDIPINE ER | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-06-16 | 2017-12-18 | 13115 |
| PMS-NIFEDIPINE ER | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-01-26 | 2018-04-19 | 37286 |
| PMS-NIFEDIPINE ER | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-09-12 | 2021-10-15 | 93825 |
| PMS-NIFEDIPINE ER | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-03-04 | 2019-09-12 | 77490 |
| PMS-NIFEDIPINE ER | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-09-08 | 2017-10-11 | 21682 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-ZOLEDRONIC ACID | 4MG | SOLUTION | Discontinued | 2017-04-07 | 2017-05-03 | 6088 |
| PMS-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117894 |
| PMS-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-07-25 | 2022-07-25 | 165469 |
| PMSC-METFORMIN | 850MG | TABLET | To be discontinued | 2025-01-28 | 2025-01-28 | 248801 |
| PMSC-METFORMIN | 500MG | TABLET | To be discontinued | 2025-01-28 | 2025-01-28 | 248798 |
| SOFLAX SYRUP 4MG/ML | 20MG | SYRUP | Discontinued | 2021-04-23 | 2021-04-23 | 138006 |
| TELMISARTAN | 80MG | TABLET | Discontinued | 2018-07-19 | 2021-10-27 | 56080 |
| TELMISARTAN | 40MG | TABLET | Discontinued | 2017-12-15 | 2018-02-02 | 33129 |
| TELMISARTAN-HCTZ | 25MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25720 |
| TELMISARTAN-HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25724 |
| TOLOXIN | 0.250MG | TABLET | Discontinued | 2020-02-05 | 2020-02-05 | 105265 |